Factors associated with discontinuation of aripiprazole treatment after switching from other antipsychotics in patients with chronic schizophrenia: A prospective observational study

Yoshikazu Takaesu, Taishiro Kishimoto, Akiko Murakoshi, Nobutada Takahashi, Yuichi Inoue

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The purpose of the study was to identify factors associated with discontinuation of aripiprazole after switching from other antipsychotics in patients with schizophrenia in real world clinical settings. From January 2011 to December 2012, a prospective, 48-week open-label study was undertaken. Thirty-eight subjects on antipsychotic monotherapy were switched to aripiprazole. Patients who discontinued aripiprazole were compared to those who continued with regards to demographic characteristics as well as treatment factors. Multiple regression analysis was conducted to identify predictors for aripiprazole discontinuation. Thirteen out of 38 patients (34.2%) discontinued aripiprazole during the follow up period. Nine patients (23.7%) discontinued aripiprazole due to worsening of psychotic symptoms. Multiple logistic regression analysis revealed that only the duration of previous antipsychotic treatment was associated with aripiprazole discontinuation after switching to aripiprazole. The receiver operating curve (ROC) analysis identified that the cut-off length for duration of illness to predict aripiprazole discontinuation was 10.5 years. Longer duration of illness was associated with aripiprazole discontinuation. Greater caution may be required when treating such patients with aripiprazole.

Original languageEnglish
Pages (from-to)71-74
Number of pages4
JournalPsychiatry Research
Volume236
DOIs
Publication statusPublished - 2016 Feb 28

Fingerprint

Antipsychotic Agents
Observational Studies
Schizophrenia
Prospective Studies
Therapeutics
Aripiprazole
Regression Analysis
Logistic Models
Demography

Keywords

  • Aripiprazole
  • Discontinuation
  • Partial agonist
  • Predictor
  • Super sensitivity
  • Switching
  • Worsening

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Factors associated with discontinuation of aripiprazole treatment after switching from other antipsychotics in patients with chronic schizophrenia : A prospective observational study. / Takaesu, Yoshikazu; Kishimoto, Taishiro; Murakoshi, Akiko; Takahashi, Nobutada; Inoue, Yuichi.

In: Psychiatry Research, Vol. 236, 28.02.2016, p. 71-74.

Research output: Contribution to journalArticle

@article{ce675f52cdda4c79bd5e25c624e6b10a,
title = "Factors associated with discontinuation of aripiprazole treatment after switching from other antipsychotics in patients with chronic schizophrenia: A prospective observational study",
abstract = "The purpose of the study was to identify factors associated with discontinuation of aripiprazole after switching from other antipsychotics in patients with schizophrenia in real world clinical settings. From January 2011 to December 2012, a prospective, 48-week open-label study was undertaken. Thirty-eight subjects on antipsychotic monotherapy were switched to aripiprazole. Patients who discontinued aripiprazole were compared to those who continued with regards to demographic characteristics as well as treatment factors. Multiple regression analysis was conducted to identify predictors for aripiprazole discontinuation. Thirteen out of 38 patients (34.2{\%}) discontinued aripiprazole during the follow up period. Nine patients (23.7{\%}) discontinued aripiprazole due to worsening of psychotic symptoms. Multiple logistic regression analysis revealed that only the duration of previous antipsychotic treatment was associated with aripiprazole discontinuation after switching to aripiprazole. The receiver operating curve (ROC) analysis identified that the cut-off length for duration of illness to predict aripiprazole discontinuation was 10.5 years. Longer duration of illness was associated with aripiprazole discontinuation. Greater caution may be required when treating such patients with aripiprazole.",
keywords = "Aripiprazole, Discontinuation, Partial agonist, Predictor, Super sensitivity, Switching, Worsening",
author = "Yoshikazu Takaesu and Taishiro Kishimoto and Akiko Murakoshi and Nobutada Takahashi and Yuichi Inoue",
year = "2016",
month = "2",
day = "28",
doi = "10.1016/j.psychres.2015.12.030",
language = "English",
volume = "236",
pages = "71--74",
journal = "Psychiatry Research",
issn = "0165-1781",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Factors associated with discontinuation of aripiprazole treatment after switching from other antipsychotics in patients with chronic schizophrenia

T2 - A prospective observational study

AU - Takaesu, Yoshikazu

AU - Kishimoto, Taishiro

AU - Murakoshi, Akiko

AU - Takahashi, Nobutada

AU - Inoue, Yuichi

PY - 2016/2/28

Y1 - 2016/2/28

N2 - The purpose of the study was to identify factors associated with discontinuation of aripiprazole after switching from other antipsychotics in patients with schizophrenia in real world clinical settings. From January 2011 to December 2012, a prospective, 48-week open-label study was undertaken. Thirty-eight subjects on antipsychotic monotherapy were switched to aripiprazole. Patients who discontinued aripiprazole were compared to those who continued with regards to demographic characteristics as well as treatment factors. Multiple regression analysis was conducted to identify predictors for aripiprazole discontinuation. Thirteen out of 38 patients (34.2%) discontinued aripiprazole during the follow up period. Nine patients (23.7%) discontinued aripiprazole due to worsening of psychotic symptoms. Multiple logistic regression analysis revealed that only the duration of previous antipsychotic treatment was associated with aripiprazole discontinuation after switching to aripiprazole. The receiver operating curve (ROC) analysis identified that the cut-off length for duration of illness to predict aripiprazole discontinuation was 10.5 years. Longer duration of illness was associated with aripiprazole discontinuation. Greater caution may be required when treating such patients with aripiprazole.

AB - The purpose of the study was to identify factors associated with discontinuation of aripiprazole after switching from other antipsychotics in patients with schizophrenia in real world clinical settings. From January 2011 to December 2012, a prospective, 48-week open-label study was undertaken. Thirty-eight subjects on antipsychotic monotherapy were switched to aripiprazole. Patients who discontinued aripiprazole were compared to those who continued with regards to demographic characteristics as well as treatment factors. Multiple regression analysis was conducted to identify predictors for aripiprazole discontinuation. Thirteen out of 38 patients (34.2%) discontinued aripiprazole during the follow up period. Nine patients (23.7%) discontinued aripiprazole due to worsening of psychotic symptoms. Multiple logistic regression analysis revealed that only the duration of previous antipsychotic treatment was associated with aripiprazole discontinuation after switching to aripiprazole. The receiver operating curve (ROC) analysis identified that the cut-off length for duration of illness to predict aripiprazole discontinuation was 10.5 years. Longer duration of illness was associated with aripiprazole discontinuation. Greater caution may be required when treating such patients with aripiprazole.

KW - Aripiprazole

KW - Discontinuation

KW - Partial agonist

KW - Predictor

KW - Super sensitivity

KW - Switching

KW - Worsening

UR - http://www.scopus.com/inward/record.url?scp=84957431443&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84957431443&partnerID=8YFLogxK

U2 - 10.1016/j.psychres.2015.12.030

DO - 10.1016/j.psychres.2015.12.030

M3 - Article

C2 - 26743338

AN - SCOPUS:84957431443

VL - 236

SP - 71

EP - 74

JO - Psychiatry Research

JF - Psychiatry Research

SN - 0165-1781

ER -